Laboratory of Pathogenic Microbiology and Immunology, College of Life Science, Jilin Agricultural University, Changchun, China.
Ministry of Education, Engineering Research Center for Bioreactor and Pharmaceutical Development, Jilin Agricultural University, Changchun, China.
Biofactors. 2019 Nov;45(6):844-856. doi: 10.1002/biof.1555. Epub 2019 Aug 16.
Autophagy is a highly conserved catabolic process and fundamental biological process in eukaryotic cells. It recycles intracellular components to provide nutrients during starvation and maintains quality control of organelles and proteins. In addition, autophagy is a well-organized homeostatic cellular process that is responsible for the removal of damaged organelles and intracellular pathogens. Moreover, it also modulates the innate and adaptive immune systems. Micro ribonucleic acids (microRNAs) are a mature class of post-transcriptional modulators that are widely expressed in tissues and organs. And, it can suppress gene expression by targeting messenger RNAs for translational repression or, at a lesser extent, degradation. Research indicates that microRNAs regulate autophagy through different pathways, playing an essential role in the treatment of various diseases. It is an important regulator of fundamental cellular processes such as proliferation, autophagy, and cell apoptosis. In this review article, we first review the current knowledge of autophagy and the function of microRNAs. Then, we summarize the mechanism of autophagy and the signaling pathways related to autophagy by citing at least the main proteins involved in the different phases of the process. Second, we introduce other members of RNA and report some examples in various pathologies. Finally, we review the current literature regarding microRNA-based therapies for cancer, atherosclerosis, cardiac disease, tuberculosis, and viral diseases. MicroRNAs can cause autophagy upregulation or downregulation by targeting genes or affecting autophagy-related signaling pathways. Therefore, the microRNAs have a huge potential in autophagy regulation, and it is the function as diagnostic and prognostic markers.
自噬是真核细胞中高度保守的分解代谢过程和基本的生物学过程。它在饥饿时回收细胞内成分以提供营养,并维持细胞器和蛋白质的质量控制。此外,自噬是一种组织良好的细胞内稳态过程,负责清除受损的细胞器和细胞内病原体。此外,它还调节先天和适应性免疫系统。微核糖核酸(miRNAs)是一类成熟的转录后调节剂,广泛表达于组织和器官中。它可以通过靶向信使 RNA 来抑制基因表达,从而进行翻译抑制或在较小程度上进行降解。研究表明,miRNAs 通过不同途径调节自噬,在治疗各种疾病中发挥重要作用。它是细胞增殖、自噬和细胞凋亡等基本细胞过程的重要调节剂。在这篇综述文章中,我们首先回顾了自噬的现有知识和 miRNAs 的功能。然后,我们通过引用参与该过程不同阶段的主要蛋白,总结了自噬的机制和与自噬相关的信号通路。其次,我们介绍了 RNA 的其他成员,并报告了在各种病理情况下的一些例子。最后,我们回顾了关于癌症、动脉粥样硬化、心脏病、结核病和病毒疾病的 miRNA 治疗的现有文献。miRNAs 可以通过靶向基因或影响自噬相关信号通路来引起自噬的上调或下调。因此,miRNAs 在自噬调节中具有巨大的潜力,并且作为诊断和预后标志物的功能。